AKCA
Akcea Therapeutics, Inc. Common Stock
AKCA
AKCA
Delisted
AKCA was delisted on the 9th of October, 2020.
58 hedge funds and large institutions have $337M invested in Akcea Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 6 closing their positions.
Holders
58
Holders Change
+13
Holders Change %
+28.89%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
19
Reduced
14
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BB
1
BB Biotech
Schaffhausen,
Switzerland
|
$21.7M |
2 |
![]()
2
Fidelity Investments
Boston,
Massachusetts
|
$173M |
3 |
3
BlackRock
New York
|
$31.7M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$20.5M |
5 |
IHM
5
Iguana Healthcare Management
New York
|
$1.74M |